(ROP) Roper Technologies, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(ROP) Roper Technologies, Inc. Bundle
See the Bigger Picture
This Roper Technologies, Inc. BCG Matrix helps you see how the company’s products or business units may be positioned across Stars, Cash Cows, Question Marks, and Dogs for strategy and capital allocation. The page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Stars
Vertafore | insurance distribution SaaS
Vertafore is one of Roper Technologies' largest vertical software franchises, and its insurance distribution SaaS stays sticky because agencies, MGAs, and carriers run daily workflows through it. In Roper's 2025 reporting, the business still fit a Star profile: high retention, cloud migration tailwinds, and growth above a mature software base as the insurance market keeps digitizing.
Deltek | project-based ERP and PSA software
Deltek looks like a Star for Roper Technologies, Inc.: it serves 30,000+ customers with mission-critical ERP and PSA tools for government contractors and project firms. Its subscription-heavy model and sticky installed base support durable growth, while cloud migration and automation still expand demand. In Roper’s 2025 portfolio, that kind of recurring software cash flow is exactly what keeps the asset high-growth and high-share.
iPipeline | life-insurance digital distribution platform
iPipeline fits a Star: it powers digital quoting, underwriting, and policy workflows in life insurance, a sticky niche with high switching costs. Roper Technologies reported 2025 sales of about $7.0 billion, showing the scale behind this platform. Its embed in carrier and distributor processes supports low churn and steady growth.
CentralReach | autism and therapy practice software
CentralReach is a Stars asset for Roper Technologies, Inc. because it serves a fast-growing behavioral-health niche: the U.S. mental-health market reached 1 in 5 adults each year, and clinics keep shifting to SaaS for scheduling, billing, and care workflows. Its recurring model supports scale, and as a newer growth engine it still deserves investment.
- Fast-growing behavioral-health demand
- SaaS drives sticky recurring revenue
- Clinic workflow integration boosts adoption
- Still in investment mode
WorkWave | field-service management SaaS
WorkWave fits Stars: it runs recurring route-based workflows in pest control, lawn care, and home services, where software use is still low. That supports sticky revenue and cross-sell as Roper keeps funding product adds and share gains. One-liner: this is a small but durable growth engine inside Roper Technologies, Inc.
- Recurring workflows lift retention.
- Underdigitized end markets aid growth.
- Roper can fund product expansion.
Roper’s Star SaaS Franchises Are Still Driving Cloud Growth in 2025
Roper Technologies, Inc.'s Stars are Vertafore, Deltek, iPipeline, CentralReach, and WorkWave: all have sticky SaaS use, high switching costs, and continued cloud-led growth in 2025. Roper Technologies, Inc. reported 2025 revenue of about $7.0 billion, and these franchises sit in underdigitized niches that still support expansion.
| Asset | 2025 fit | Key point |
|---|---|---|
| Vertafore | Star | Insurance SaaS |
| Deltek | Star | 30,000+ customers |
What is included in the product
Detailed Word Document
Roper Technologies BCG Matrix: classifies its software and niche industrial businesses into Stars, Cash Cows, Question Marks, and Dogs.
Editable Excel File
Quickly spot Roper’s business units by quadrant to simplify portfolio decisions.
Reference Sources
Provides a credible source trail for Roper Technologies, making key claims easier to verify and decisions faster to defend.
Cash Cows
Aderant | legal practice management software
Aderant fits Cash Cows: it serves large law firms with billing, practice, and financial systems, and sticky workflows keep churn low. Roper does not break out Aderant revenue, but Roper posted $7.0B revenue in 2024 and strong cash flow, showing the kind of steady, low-capex engine this unit supports.
CBORD | campus and foodservice software
CBORD is a classic Cash Cow: it serves campus commerce, foodservice, and access control with a sticky installed base, and swaps are slow because customers rely on deep workflow integration. Roper does not break out CBORD standalone 2025 revenue, but it sits in a portfolio that produced strong cash generation, with Roper’s 2025 adjusted EBITDA margin near 43%. Growth trails newer SaaS assets, yet recurring renewals and low churn support durable free cash flow.
PowerPlan | asset-intensive industry software
PowerPlan fits a cash cow profile because it serves utilities, energy, and other capital-heavy industries where compliance, planning, and regulatory workflows matter more than frequent feature changes.
That kind of sticky, mission-critical use supports steady renewal revenue and low churn, which is why mature asset-intensive software often throws off strong cash even with modest growth.
For Roper Technologies, Inc., the value is in durable demand and pricing power, not rapid expansion; these workflows stay embedded in customer operations for years.
Verathon | airway and bladder ultrasound devices
Verathon is a niche airway and bladder ultrasound business with a sticky installed base, so hospitals buy it for reliability and repeat use, not fast category growth. That profile fits a Cash Cow in Roper Technologies, Inc. BCG Matrix: mature demand, high switching costs, and steady replacement sales support dependable cash flow.
- High clinical need, low growth
- Large installed base supports repeat sales
- Hospitals value reliability over novelty
- Cash generation should stay strong
CIVCO Medical Solutions | procedure accessories and imaging tools
CIVCO Medical Solutions fits a Cash Cow because its procedure accessories and imaging tools drive repeat replacement demand in stable care settings, not hype-driven growth. Roper Technologies, Inc. reported strong 2025 cash generation, with free cash flow still a core priority, which suits a business like CIVCO that can keep producing steady cash instead of chasing breakout expansion.
- Recurring consumable demand
- Stable, less cyclical end markets
- Better for cash harvesting
Roper’s Cash Cow Engines: Sticky, Durable, and Highly Profitable
Aderant, CBORD, PowerPlan, Verathon, and CIVCO fit Cash Cows: they serve sticky, mission-critical workflows with low churn and repeat demand. Roper Technologies, Inc. posted $7.0B revenue in 2024 and about 43% adjusted EBITDA margin in 2025, showing the cash power of these mature assets. Growth is modest, but renewal income and pricing power stay durable.
| Unit | Cash Cow signal |
|---|---|
| Aderant | High switching costs |
| CBORD | Sticky installed base |
| PowerPlan | Regulatory need |
| Verathon | Repeat replacements |
Get Your Copy
Roper Technologies, Inc. Reference Sources
This preview shows the exact Roper Technologies, Inc. BCG Matrix report you’ll receive after purchase. The full document is the same polished, ready-to-use file—no demo pages, no hidden changes. Once purchased, it’s instantly available for download and use.
Dogs
Legacy rubber and plastic test instruments
Legacy rubber and plastic test instruments sit in a slow-growth niche inside Roper Technologies, Inc. Demand is tied to mature industrial testing cycles, not fast software adoption. That makes this more of a cash-harvest asset than a growth engine, so it fits a Cash Cow profile.
Flow and control components
Flow and control components fit the Dogs box: valves, pumps, and meters sell into mature industrial markets where specs and price drive wins, not fast growth. For Roper Technologies, this looks more like a low-growth hold asset than a Star, with limited pricing power and heavy competition. Unless end-markets reaccelerate, capital is better directed to higher-return software and data businesses.
Leak detection and vibration monitoring hardware
Leak detection and vibration monitoring hardware sits in the low-growth, niche part of Roper Technologies, Inc.’s portfolio. Unlike recurring SaaS, demand is lumpier because hardware replacement and retrofit cycles depend on plant capex timing. Roper’s model still favors software-like revenue, so these products are more likely to be Dogs unless they hold share in a stable installed base.
Industrial and utility sensors
Industrial and utility sensors fit the Dogs bucket because mature sensor channels usually grow with replacement and maintenance, not new category demand. That makes pricing tougher and share gains harder, which can cap returns. Roper Technologies, Inc. has kept margins strong overall, but this line still tends to face commoditization and lower growth than its software-heavy peers.
- Maintenance-led demand
- High commoditization pressure
- Harder share gains
- Lower return profile
Low-scale medical accessories
Roper Technologies, Inc. has $7.7 billion of 2024 revenue, but smaller medical accessory lines are far less scalable than its software units. Without recurring subscription revenue, these businesses tend to stay stable yet low-share, which fits the BCG dog quadrant. One-liner: steady cash, weak growth.
- Limited scale
- No subscription lift
- Low share, low growth
- Dog-like fit
Roper’s Dogs: Steady Cash, Weak Growth, Little Reinvestment Appeal
Dogs in Roper Technologies, Inc. are mature hardware lines with slow end-market growth, weak pricing power, and capex-tied demand. They fit a low-share, low-growth profile, so cash is steady but reinvestment appeal is thin.
| Signal | Read |
|---|---|
| Growth | Low |
| Demand | Replacement-led |
| Economics | Commoditized |
| BCG fit | Dog |
Question Marks
AI-enabled workflow add-ons
Roper Technologies, Inc. is adding AI features across multiple software platforms, but adoption is still early, so these add-ons fit the Question Marks bucket: high upside, low share. Roper's 2025 software base should help fund this buildout, yet monetization is not proven enough to call these market leaders. Until usage, pricing, and retention show clear lift, these AI tools remain investment-heavy bets.
New cloud modules in Frontline Education
Frontline Education’s new cloud modules fit Question Marks: it serves K-12 attendance, staffing, and compliance, while the U.S. public school market still covers about 49.5 million students. Demand for cloud admin tools is growing, so adjacent-module share can still be built. But the expansion case is not yet proven, so Roper needs more sales wins and cross-sell traction.
ConstructConnect | preconstruction network software
ConstructConnect is a question mark in Roper Technologies, Inc.'s BCG Matrix because it serves construction bidding and project intelligence in a market that is still fragmented, even as digital workflows keep growing. Roper's 2025 push into higher-margin software supports more investment here, but the unit still needs stronger share and scale to shift from a niche player to a star. If adoption keeps rising, its network effects could improve win rates and pricing power.
Healthcare workflow expansion
Roper keeps pushing software into clinical and admin workflows, so this Healthcare workflow expansion sits in the question-mark bucket: the market is big, but adoption still decides the payoff. U.S. healthcare spending is projected to reach $5.3 trillion in 2025, so the runway is real. New modules must prove stickiness, lower friction, and lift usage before they can scale.
- Large market, uncertain conversion
- Adoption drives future scale
- High upside, still unproven
Renewables and energy-transition software extensions
Renewables and energy-transition software fits a Question Mark: demand is rising as utilities chase compliance, grid optimization, and lower-carbon assets, but Roper still needs proof it can win share. In FY2025, Roper generated roughly $7B of revenue, so this niche must scale fast enough to earn more capital, not just add optional growth.
- Fast growth, weak share
- Utility spending is shifting
- Capital needs clear payback
If these products keep taking share in a market that is expanding toward decarbonization and asset analytics, they can move toward Star status; if not, they stay a costly bet.
Roper’s Question Marks: Big Markets, Early Proof
Roper Technologies, Inc.’s Question Marks are early-stage bets with big markets but weak proof of scale. Roper Technologies, Inc. posted about $7.0B revenue in FY2025, while U.S. healthcare spending is projected at $5.3T in 2025 and public schools serve about 49.5M students, so the runway is real. Still, these products need clearer adoption, pricing, and retention gains before they can move up.
| Area | Status | Key data |
|---|---|---|
| AI add-ons | Question Mark | Early adoption, unproven monetization |
| Frontline Education | Question Mark | 49.5M U.S. students |
| Healthcare workflow | Question Mark | $5.3T U.S. spend in 2025 |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.